InsidersTradesSigma
Track the RetinalGenix Technologies Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €75.4m. The latest transaction was reported on 10 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Steven Bayern for Bayern Capital LLC. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
RetinalGenix Technologies Inc. 是一家专注于开发眼部健康技术解决方案的公司。该公司在纳斯达克上市，股票代码为 XNAS。